Evidence map›Paper›PMID 38950288›Full record

ArticleThe Journal of clinical investigation2024

Frameshift variants in C10orf71 cause dilated cardiomyopathy in human, mouse, and organoid models.

Yang Li, Ke Ma, Zhujun Dong, Shijuan Gao, Jing Zhang, Shan Huang, Jie Yang, Guangming Fang, Yujie Li, Xiaowei Li and 10 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Observational
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Discovery ofDiagnostics (Basel, Switzerland) · 2025
    Article
  10. Generation and applications of cardiac spheroids.npj biomedical innovations · 2025
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Yang LiBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ke MaBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zhujun DongBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Shijuan GaoBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jing ZhangBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Shan HuangBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jie YangBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Guangming FangBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yujie LiNovogene Co. Ltd., Beijing, China.
Xiaowei LiDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Carrie WelchDepartment of Pediatrics, Columbia University, New York, New York, USA.
Emily L GriffinDepartment of Pediatrics, Columbia University, New York, New York, USA.
Prema RamaswamyMaimonides Medical Center, New York, New York, USA.
Zaheer ValivullahBroad Institute, Cambridge, Massachusetts, USA.
Xiuying LiuChangping Laboratory, Beijing, China.
Jianzeng DongBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Dao Wen WangDivision of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jie DuBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Wendy K ChungBoston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Yulin LiBeijing Anzhen Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research advances over the past 30 years have confirmed a critical role for genetics in the etiology of dilated cardiomyopathies (DCMs). However, full knowledge of the genetic architecture of DCM remains incomplete. We identified candidate DCM causal gene, C10orf71, in a large family with 8 patients with DCM by whole-exome sequencing. Four loss-of-function variants of C10orf71 were subsequently identified in an additional group of492 patients with sporadic DCM from 2 independent cohorts. C10orf71 was found to be an intrinsically disordered protein specifically expressed in cardiomyocytes. C10orf71-KO mice had abnormal heart morphogenesis during embryonic development and cardiac dysfunction as adults with altered expression and splicing of contractile cardiac genes. C10orf71-null cardiomyocytes exhibited impaired contractile function with unaffected sarcomere structure. Cardiomyocytes and heart organoids derived from human induced pluripotent stem cells with C10orf71 frameshift variants also had contractile defects with normal electrophysiological activity. A rescue study using a cardiac myosin activator, omecamtiv mecarbil, restored contractile function in C10orf71-KO mice. These data support C10orf71 as a causal gene for DCM by contributing to the contractile function of cardiomyocytes. Mutation-specific pathophysiology may suggest therapeutic targets and more individualized therapy.

Indexed as

Cardiomyopathy, DilatedFrameshift MutationMice, KnockoutMyocytes, CardiacOrganoidsAdultAnimalsCarrier ProteinsDisease Models, AnimalFemaleHumansIntercellular Signaling Peptides and ProteinsMaleMiceMyocardial ContractionC10orf71 protein, humanCarrier ProteinsCefip protein, mouseIntercellular Signaling Peptides and ProteinsCardiologyCardiovascular diseaseGenetic diseasesGeneticsGenetic variation

Identifiers

PMID38950288
PMCPMC11178530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.